Prelude Therapeutics (NasdaqGS:PRLD) Earnings Call Presentation

Corporate Presentation March 2026 Confidential Forward Looking Statements & Disclaimers This presentation contains "forward-looking" statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, anticipated discovery, preclinical and clinical development activities for Prelude's product candidates and milestones, the potential safety, efficacy, benefits and addressable market for Prelude Therapeutic Incorporated's (the " ...